Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 18.59%5.08B | 4.19%2.78B | 15.47%13.73B | 18.53%4.47B | 7.63%2.3B | 33.32%4.28B | -3.38%2.67B | 2.70%11.89B | 10.75%3.77B | 16.99%2.14B |
Cost of revenue | 11.12%3.21B | -1.46%1.71B | 14.93%9.12B | 16.52%2.89B | 9.31%1.61B | 33.44%2.89B | -4.68%1.74B | -0.34%7.93B | 3.89%2.48B | 12.09%1.47B |
Gross profit | 34.07%1.87B | 14.66%1.07B | 16.54%4.61B | 22.35%1.59B | 3.94%693.64M | 33.07%1.39B | -0.88%935.62M | 9.40%3.96B | 26.70%1.3B | 29.43%667.32M |
Operating expense | 21.82%898.85M | 9.48%827.03M | 6.79%3.34B | 9.04%1B | 19.11%848.21M | -2.71%737.82M | 1.89%755.43M | 22.83%3.13B | 19.16%919.64M | 18.78%712.13M |
Staff costs | ---- | ---- | 5.30%1.22B | ---- | ---- | ---- | ---- | 1.99%1.16B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | 14.48%333.66M | ---- | ---- | ---- | ---- | 26.13%291.45M | ---- | ---- |
-Selling and marketing expense | ---- | ---- | 3.75%183.23M | ---- | ---- | ---- | ---- | 20.73%176.6M | ---- | ---- |
-General and administrative expense | ---- | ---- | 30.99%150.43M | ---- | ---- | ---- | ---- | 35.44%114.85M | ---- | ---- |
Research and development costs | ---- | ---- | -9.14%703.96M | ---- | ---- | ---- | ---- | 97.34%774.74M | ---- | ---- |
Depreciation and amortization | ---- | ---- | 46.92%103.54M | ---- | ---- | ---- | ---- | 13.10%70.48M | ---- | ---- |
-Depreciation | ---- | ---- | 46.92%103.54M | ---- | ---- | ---- | ---- | 21.24%70.48M | ---- | ---- |
Rent and land expenses | ---- | ---- | 0.76%81.83M | ---- | ---- | ---- | ---- | 4.16%81.21M | ---- | ---- |
Other operating expenses | ---- | ---- | 19.44%896.84M | ---- | ---- | ---- | ---- | 16.32%750.89M | ---- | ---- |
Operating profit | 47.84%970.09M | 36.36%245.71M | 53.54%1.27B | 54.70%584.98M | -244.94%-154.57M | 126.91%656.16M | -11.02%180.19M | -22.69%825.02M | 49.76%378.14M | 46.63%-44.81M |
Net non-operating interest income (expenses) | -179.77%-990K | 80.03%-635K | 70.20%-5.92M | 10.92%-4.27M | 106.32%294K | 124.69%1.24M | 40.91%-3.18M | 18.79%-19.86M | 26.31%-4.8M | 20.16%-4.65M |
Non-operating interest income | -84.91%555K | 1.07%1.13M | 2,986.19%11.17M | 2,041.05%4.07M | 2,492.13%2.31M | 5,310.29%3.68M | 7,353.33%1.12M | -15.22%362K | 166.90%190K | -62.76%89K |
Non-operating interest expense | -36.63%1.55M | -58.92%1.77M | -15.48%17.09M | 67.24%8.34M | -57.56%2.01M | -52.14%2.44M | -20.35%4.3M | -18.73%20.22M | -19.90%4.99M | -21.84%4.74M |
Net investment income | 104.55%135.73M | -38.56%-66.17M | -23.50%319.11M | 91.58%74.9M | 37.73%225.61M | -57.98%66.36M | -184.79%-47.75M | 181.23%417.13M | 423.65%39.09M | 1,226.85%163.8M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -76.07%19.77M | 0 | 82.61M | 0 | 0 | |||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -483.77%-1.32M | 721K | -568.63%-178.68M | 18,466.67%551K | -1,496,333.33%-179.57M | 345K | 0 | -16.74%38.13M | -100.01%-3K | 86.81%-12K |
Less:Other special charges | ---- | ---- | 489.72%148.59M | -42,033.33%-1.26M | 1,251,491.67%150.19M | ---- | ---- | 16.74%-38.13M | 100.01%3K | -86.81%12K |
Less:Write off | --1.32M | ---721K | --30.09M | --707K | --29.38M | --0 | --0 | --0 | --0 | ---- |
Other non-operating income (expenses) | 18.60%9.22M | 369.90%11.15M | 58.29%24.3M | -6.27%6.36M | 304.09%7.8M | 539.51%7.77M | -56.27%2.37M | -87.12%15.35M | -62.04%6.78M | -82.21%1.93M |
Income before tax | 52.04%1.11B | 44.93%190.77M | 6.40%1.45B | 58.04%662.5M | -169.39%-80.67M | 61.20%731.88M | -64.32%131.63M | 0.17%1.36B | 40.54%419.21M | 274.33%116.25M |
Income tax | 59.04%281.58M | -218.81%-64.97M | 10.96%319.18M | 102.11%113.95M | -188.73%-26.49M | 52.98%177.04M | -56.16%54.68M | -26.42%287.66M | -21.82%56.38M | -4,465.17%-9.18M |
Net income | 49.80%831.14M | 232.36%255.74M | 5.18%1.13B | 51.19%548.56M | -143.19%-54.18M | 64.01%554.83M | -68.49%76.95M | 10.95%1.07B | 60.42%362.83M | 288.66%125.43M |
Net income continuous operations | 49.80%831.14M | 232.36%255.74M | 5.18%1.13B | 51.19%548.55M | -143.19%-54.18M | 64.01%554.83M | -68.49%76.95M | 10.95%1.07B | 60.42%362.83M | 288.66%125.43M |
Noncontrolling interests | 0 | 0 | -82.65%4.82M | -99.77%59K | 102.82%105K | |||||
Net income attributable to the company | 49.80%831.14M | 232.36%255.74M | 5.65%1.13B | 51.21%548.56M | -143.23%-54.18M | 65.39%554.83M | -68.25%76.95M | 13.72%1.07B | 80.82%362.77M | 299.69%125.32M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 49.80%831.14M | 232.36%255.74M | 5.65%1.13B | 51.21%548.56M | -143.23%-54.18M | 65.39%554.83M | -68.25%76.95M | 13.72%1.07B | 80.82%362.77M | 299.69%125.32M |
Gross dividend payment | ||||||||||
Basic earnings per share | 48.63%50.61 | 231.99%15.67 | 5.64%69.11 | 51.15%33.66 | -143.17%-3.32 | 65.37%34.05 | -68.26%4.72 | 13.73%65.42 | 80.91%22.27 | 299.74%7.69 |
Diluted earnings per share | 48.63%50.61 | 231.99%15.67 | 5.64%69.11 | 51.18%33.6593 | -143.24%-3.3252 | 65.38%34.05 | -68.26%4.72 | 13.73%65.42 | 80.87%22.2647 | 299.65%7.69 |
Dividend per share | 0 | 0 | 20.00%12 | 20.00%12 | 0 | 0 | 0 | 17.65%10 | 17.65%10 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |